OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Treatment with anagliptin, a DPP-4 inhibitor, decreases FABP4 concentration in patients with type 2 diabetes mellitus at a high risk for cardiovascular disease who are receiving statin therapy
Masato Furuhashi, Ichiro Sakuma, Takeshi Morimoto, et al.
Cardiovascular Diabetology (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 22
Masato Furuhashi, Ichiro Sakuma, Takeshi Morimoto, et al.
Cardiovascular Diabetology (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 22
Showing 22 citing articles:
Dipeptidyl peptidase-4 inhibitors, glucagon-like peptide 1 receptor agonists and sodium-glucose co-transporter-2 inhibitors for people with cardiovascular disease: a network meta-analysis
Takayoshi Kanie, Atsushi Mizuno, Yoshimitsu Takaoka, et al.
Cochrane library (2021) Vol. 2021, Iss. 10
Open Access | Times Cited: 61
Takayoshi Kanie, Atsushi Mizuno, Yoshimitsu Takaoka, et al.
Cochrane library (2021) Vol. 2021, Iss. 10
Open Access | Times Cited: 61
FABP4 secreted by M1-polarized macrophages promotes synovitis and angiogenesis to exacerbate rheumatoid arthritis
Dong Guo, Chuangxin Lin, Yuheng Lu, et al.
Bone Research (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 59
Dong Guo, Chuangxin Lin, Yuheng Lu, et al.
Bone Research (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 59
Adipose extracellular matrix deposition is an indicator of obesity and metabolic disorders
Hui-jian Chen, Xiyue Yan, Ao Sun, et al.
The Journal of Nutritional Biochemistry (2022) Vol. 111, pp. 109159-109159
Closed Access | Times Cited: 25
Hui-jian Chen, Xiyue Yan, Ao Sun, et al.
The Journal of Nutritional Biochemistry (2022) Vol. 111, pp. 109159-109159
Closed Access | Times Cited: 25
Elevated circulating FABP4 concentration predicts cardiovascular death in a general population: a 12-year prospective study
Norie Saito, Masato Furuhashi, Masayuki Koyama, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 32
Norie Saito, Masato Furuhashi, Masayuki Koyama, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 32
The Effects of FABP4 on Cardiovascular Disease in the Aging Population
Ellen M. van der Ark-Vonk, Mike V. Puijk, Gerard Pasterkamp, et al.
Current Atherosclerosis Reports (2024) Vol. 26, Iss. 5, pp. 163-175
Open Access | Times Cited: 4
Ellen M. van der Ark-Vonk, Mike V. Puijk, Gerard Pasterkamp, et al.
Current Atherosclerosis Reports (2024) Vol. 26, Iss. 5, pp. 163-175
Open Access | Times Cited: 4
The impact of DPP-4 inhibitors on cardiovascular disease treatment: a comprehensive review of current therapeutic strategies and future directions
Toka Elemary, Mina Nicola, Mohamed E. A. Abdelrahim, et al.
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access
Toka Elemary, Mina Nicola, Mohamed E. A. Abdelrahim, et al.
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access
Independent and Distinct Associations of FABP4 and FABP5 With Metabolic Parameters in Type 2 Diabetes Mellitus
Masato Furuhashi, Ichiro Sakuma, Takeshi Morimoto, et al.
Frontiers in Endocrinology (2020) Vol. 11
Open Access | Times Cited: 23
Masato Furuhashi, Ichiro Sakuma, Takeshi Morimoto, et al.
Frontiers in Endocrinology (2020) Vol. 11
Open Access | Times Cited: 23
DPP-4 Inhibitors Suppress Tau Phosphorylation and Promote Neuron Autophagy through the AMPK/mTOR Pathway to Ameliorate Cognitive Dysfunction in Diabetic Mellitus
Ying Hu, Jixiong Xu, Jiancheng Wang, et al.
ACS Chemical Neuroscience (2023) Vol. 14, Iss. 18, pp. 3335-3346
Closed Access | Times Cited: 8
Ying Hu, Jixiong Xu, Jiancheng Wang, et al.
ACS Chemical Neuroscience (2023) Vol. 14, Iss. 18, pp. 3335-3346
Closed Access | Times Cited: 8
Tackling type 2 diabetes-associated cardiovascular and renal comorbidities: a key challenge for drug development
Ernest Adeghate, Huba Kalász, Saeeda Al Jaberi, et al.
Expert Opinion on Investigational Drugs (2020) Vol. 30, Iss. 2, pp. 85-93
Open Access | Times Cited: 16
Ernest Adeghate, Huba Kalász, Saeeda Al Jaberi, et al.
Expert Opinion on Investigational Drugs (2020) Vol. 30, Iss. 2, pp. 85-93
Open Access | Times Cited: 16
Development of FABP4/5 inhibitors with potential therapeutic effect on type 2 Diabetes Mellitus
Yulong He, Min‐Te Chen, Ting Wang, et al.
European Journal of Medicinal Chemistry (2021) Vol. 224, pp. 113720-113720
Closed Access | Times Cited: 12
Yulong He, Min‐Te Chen, Ting Wang, et al.
European Journal of Medicinal Chemistry (2021) Vol. 224, pp. 113720-113720
Closed Access | Times Cited: 12
Effects of anagliptin on the stress induced accelerated senescence of human umbilical vein endothelial cells
Seon Mee Kang, Hye Sook Jung, Min Jeong Kwon, et al.
Annals of Translational Medicine (2021) Vol. 9, Iss. 9, pp. 750-750
Open Access | Times Cited: 11
Seon Mee Kang, Hye Sook Jung, Min Jeong Kwon, et al.
Annals of Translational Medicine (2021) Vol. 9, Iss. 9, pp. 750-750
Open Access | Times Cited: 11
Serum fatty acid-binding protein 4 levels and responses of pancreatic islet β-cells and α-cells in patients with type 2 diabetes
Hong Wang, Jie Cao, Jianbin Su, et al.
Diabetology & Metabolic Syndrome (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 11
Hong Wang, Jie Cao, Jianbin Su, et al.
Diabetology & Metabolic Syndrome (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 11
Anagliptin prevents lipopolysaccharide (LPS)- induced inflammation and activation of macrophages
Fang-fang Yu, Wenxia Tian, Jie Dong
International Immunopharmacology (2022) Vol. 104, pp. 108514-108514
Closed Access | Times Cited: 6
Fang-fang Yu, Wenxia Tian, Jie Dong
International Immunopharmacology (2022) Vol. 104, pp. 108514-108514
Closed Access | Times Cited: 6
Friend or foe for obesity: How hepatokines remodel adipose tissues and translational perspective
Yao Zhang, Yibing Wang, Junli Liu
Genes & Diseases (2022) Vol. 10, Iss. 3, pp. 825-847
Open Access | Times Cited: 5
Yao Zhang, Yibing Wang, Junli Liu
Genes & Diseases (2022) Vol. 10, Iss. 3, pp. 825-847
Open Access | Times Cited: 5
Dipeptidyl peptidase-4 inhibition prevents lung injury in mice under chronic stress via the modulation of oxidative stress and inflammation
Shengming Zhang, Ping Li, Minglong Xin, et al.
EXPERIMENTAL ANIMALS (2021) Vol. 70, Iss. 4, pp. 541-552
Open Access | Times Cited: 7
Shengming Zhang, Ping Li, Minglong Xin, et al.
EXPERIMENTAL ANIMALS (2021) Vol. 70, Iss. 4, pp. 541-552
Open Access | Times Cited: 7
Differential Effects of DPP-4 Inhibitors, Anagliptin and Sitagliptin, on PCSK9 Levels in Patients with Type 2 Diabetes Mellitus who are Receiving Statin Therapy
Masato Furuhashi, Ichiro Sakuma, Takeshi Morimoto, et al.
Journal of Atherosclerosis and Thrombosis (2020) Vol. 29, Iss. 1, pp. 24-37
Open Access | Times Cited: 6
Masato Furuhashi, Ichiro Sakuma, Takeshi Morimoto, et al.
Journal of Atherosclerosis and Thrombosis (2020) Vol. 29, Iss. 1, pp. 24-37
Open Access | Times Cited: 6
Effect of Add-On Therapy of Sodium-Glucose Cotransporter 2 Inhibitors and Dipeptidyl Peptidase 4 Inhibitors on Adipokines in Type 2 Diabetes Mellitus
Abid Shaheer, Ashok Kumar, P.B. Menon, et al.
Journal of Clinical Medicine Research (2021) Vol. 13, Iss. 6, pp. 355-362
Open Access | Times Cited: 5
Abid Shaheer, Ashok Kumar, P.B. Menon, et al.
Journal of Clinical Medicine Research (2021) Vol. 13, Iss. 6, pp. 355-362
Open Access | Times Cited: 5
Synthesis of 4-(pyrazol-1-yl)pyrimidines from 4-hydrazinopyrimidines and investigation of their structure and some chemical properties
G. G. Danagulyan, Meline R. Arakelyan, Nicolai A. Aksenov, et al.
Journal of Molecular Structure (2023) Vol. 1295, pp. 136676-136676
Closed Access | Times Cited: 1
G. G. Danagulyan, Meline R. Arakelyan, Nicolai A. Aksenov, et al.
Journal of Molecular Structure (2023) Vol. 1295, pp. 136676-136676
Closed Access | Times Cited: 1
Diabetes-Induced Cardiomyopathy: Updates in Epidemiology, Prevention, and Management
Ernest Adeghate, Sahar Mohsin, A. Amar, et al.
IntechOpen eBooks (2024)
Closed Access
Ernest Adeghate, Sahar Mohsin, A. Amar, et al.
IntechOpen eBooks (2024)
Closed Access
Adipocyte “Fatty Acid Binding Protein” Gene Polymorphisms (rs1054135, rs16909196 and rs16909187) in Jordanians with Obesity and Type 2 Diabetes Mellitus
S.W. El-Ryalat, Yacoub M. Irshaid, M. Abujbara, et al.
Balkan Journal of Medical Genetics (2022) Vol. 25, Iss. 2, pp. 63-70
Open Access | Times Cited: 2
S.W. El-Ryalat, Yacoub M. Irshaid, M. Abujbara, et al.
Balkan Journal of Medical Genetics (2022) Vol. 25, Iss. 2, pp. 63-70
Open Access | Times Cited: 2
Rol de nuevos fármacos antidiabéticos en prevención cardiovascular e insuficiencia cardiaca
Jesús Miguel Rojas-Velázquez, Alejandro Giralt-Herrera, Jessica Leiva-Enríquez, et al.
Clínica e Investigación en Arteriosclerosis (2021) Vol. 33, Iss. 6, pp. 314-322
Closed Access
Jesús Miguel Rojas-Velázquez, Alejandro Giralt-Herrera, Jessica Leiva-Enríquez, et al.
Clínica e Investigación en Arteriosclerosis (2021) Vol. 33, Iss. 6, pp. 314-322
Closed Access
Role of newer antidiabetic drugs on cardiovascular prevention and heart failure
Jesús Miguel Rojas-Velázquez, Alejandro Giralt-Herrera, Jessica Leiva-Enríquez, et al.
Clínica e Investigación en Arteriosclerosis (English Edition) (2021) Vol. 33, Iss. 6, pp. 314-322
Closed Access
Jesús Miguel Rojas-Velázquez, Alejandro Giralt-Herrera, Jessica Leiva-Enríquez, et al.
Clínica e Investigación en Arteriosclerosis (English Edition) (2021) Vol. 33, Iss. 6, pp. 314-322
Closed Access
